Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00589420
Title Sorafenib and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Sorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.